Humana Press, 2013. — 414 p. — (Current Clinical Oncology).
Recently, understanding the molecular pathogenesis of malignant lymphomas has led to improvement in the diagnostic precision and to the identification of a variety of molecular therapeutic targets. In addition, new drugs have been approved in the US and Europe, resulting in changes in the standard of care of several types of lymphoid malignancies. Comprehensive in scope and developed by a team of internationally renowned authors, Lymphoma: Diagnosis and Treatment provides a timely update on the most important advances in the biology, diagnosis, and therapy of lymphomas. As part of the Current Clinical Oncology series, Lymphoma: Diagnosis and Treatment will be of value to medical oncologists, hematologists, radiation oncologists, and all physicians involved in the care of patients with lymphoid malignancies.
The World Health Organization Classification of Lymphoid Neoplasms
Genomic Analysis of B-Cell Lymphomas
Molecular Profiling of Peripheral T-Cell Lymphomas
Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia
Waldenström’s Macroglobulinemia/Lymphoplasmacytic Lymphoma
MALT Lymphoma (Extranodal Marginal Zone B-Cell Lymphoma)
Splenic Marginal Zone Lymphoma
Nodal Marginal Zone Lymphoma
Follicular Lymphoma
Mantle Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Primary Mediastinal B-Cell Lymphoma
T-Cell Lymphomas
Burkitt Lymphoma
Lymphoblastic Lymphoma
AIDS-Related Lymphoma
Posttransplant Lymphomas
Cutaneous B-Cell Lymphoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
Central Nervous System Lymphoma
Monoclonal Antibodies for Lymphoma
Novel Agents Targeting Oncogenic Pathways in Lymphoma
Stem Cell Transplantation for Non-Hodgkin’s Lymphomas